Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

S.G.R. Verelst; F. Termorshuizen; C.A. Uyl-de Groot; M.R. Schaafsma; A.H.M. Ammerlaan; S. Wittebol; H.A.M. Sinnige; S. Zweegman; M.V. Kooy; R. van der Griend; H.M. Lokhorst; P. Sonneveld; P.W. Wijermans

doi:10.1007/s00277-011-1224-1

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

S.G.R. Verelst, F. Termorshuizen, C.A. Uyl-de Groot, M.R. Schaafsma, A.H.M. Ammerlaan, S. Wittebol, H.A.M. Sinnige, S. Zweegman, M.V. Kooy, R. van der Griend, H.M. Lokhorst, P. Sonneveld, P.W. Wijermans

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

192 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1427-1439
Journal	Annals of Hematology
Volume	90
Issue number	12
DOIs	https://doi.org/10.1007/s00277-011-1224-1
Publication status	Published - 2011

Access to Document

10.1007/s00277-011-1224-1

282005Final published version, 274 KB

Cite this

Verelst, S. G. R., Termorshuizen, F., Uyl-de Groot, C. A., Schaafsma, M. R., Ammerlaan, A. H. M., Wittebol, S., Sinnige, H. A. M., Zweegman, S., Kooy, M. V., van der Griend, R., Lokhorst, H. M., Sonneveld, P., & Wijermans, P. W. (2011). Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial. Annals of Hematology, 90(12), 1427-1439. https://doi.org/10.1007/s00277-011-1224-1

@article{65b8003a371144a39b568d917442670a,

title = "Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial",

author = "S.G.R. Verelst and F. Termorshuizen and {Uyl-de Groot}, C.A. and M.R. Schaafsma and A.H.M. Ammerlaan and S. Wittebol and H.A.M. Sinnige and S. Zweegman and M.V. Kooy and {van der Griend}, R. and H.M. Lokhorst and P. Sonneveld and P.W. Wijermans",

year = "2011",

doi = "10.1007/s00277-011-1224-1",

language = "Undefined/Unknown",

volume = "90",

pages = "1427--1439",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Verlag",

number = "12",

}

Verelst, SGR, Termorshuizen, F, Uyl-de Groot, CA, Schaafsma, MR, Ammerlaan, AHM, Wittebol, S, Sinnige, HAM, Zweegman, S, Kooy, MV, van der Griend, R, Lokhorst, HM, Sonneveld, P & Wijermans, PW 2011, 'Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial', Annals of Hematology, vol. 90, no. 12, pp. 1427-1439. https://doi.org/10.1007/s00277-011-1224-1

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial. / Verelst, S.G.R.; Termorshuizen, F.; Uyl-de Groot, C.A. et al.

In: Annals of Hematology, Vol. 90, No. 12, 2011, p. 1427-1439.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

AU - Verelst, S.G.R.

AU - Termorshuizen, F.

AU - Uyl-de Groot, C.A.

AU - Schaafsma, M.R.

AU - Ammerlaan, A.H.M.

AU - Wittebol, S.

AU - Sinnige, H.A.M.

AU - Zweegman, S.

AU - Kooy, M.V.

AU - van der Griend, R.

AU - Lokhorst, H.M.

AU - Sonneveld, P.

AU - Wijermans, P.W.

PY - 2011

Y1 - 2011

U2 - 10.1007/s00277-011-1224-1

DO - 10.1007/s00277-011-1224-1

M3 - Article

C2 - 21472373

VL - 90

SP - 1427

EP - 1439

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 12

ER -